Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
injection
|
| gptkbp:alternativeName |
gptkb:TAK-003
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:contains |
gptkb:attenuated_dengue_virus
|
| gptkbp:developedBy |
gptkb:Takeda_Pharmaceutical_Company
dengue fever |
| https://www.w3.org/2000/01/rdf-schema#label |
DENVax
|
| gptkbp:protectedBy |
gptkb:DENV-1
gptkb:DENV-2 gptkb:DENV-3 gptkb:DENV-4 |
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:status |
under regulatory review (as of 2023)
|
| gptkbp:targetAudience |
adults
children |
| gptkbp:type |
gptkb:tetravalent_dengue_vaccine
|
| gptkbp:bfsParent |
gptkb:Inviragen
|
| gptkbp:bfsLayer |
7
|